These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9732877)

  • 1. Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Lady Davis Carmel Medical Center.
    Halon DA; Merdler A; Flugelman MY; Shifroni G; Khader N; Shiran A; Shahla J; Lewis BS
    Am J Cardiol; 1998 Sep; 82(5):547-53. PubMed ID: 9732877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center registry).
    Halon DA; Merdler A; Flugelman MY; Rennert HS; Weisz G; Shahla J; Lewis BS
    Am J Cardiol; 2000 Jun; 85(12):1420-6. PubMed ID: 10856386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar late revascularization rates 10 to 12 years after angioplasty or bypass surgery for multivessel coronary artery disease: a report from the Lady Davis Carmel Medical Center (LDCMC) Registry.
    Halon DA; Flugelman MY; Merdler A; Rennert HS; Weisz G; Shahla J; Lewis BS
    Am J Cardiol; 2000 Nov; 86(10):1131-4, A6. PubMed ID: 11074213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of late repeat hospitalization in patients undergoing angioplasty or bypass surgery. A long-term (13 years) report from the Lady Davis Carmel Medical Center registry.
    Halon DA; Rennert HS; Flugelman MY; Jaffe R; Lewis BS
    Cardiology; 2002; 98(1-2):67-74. PubMed ID: 12373050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Ellis SG; Cowley MJ; Whitlow PL; Vandormael M; Lincoff AM; DiSciascio G; Dean LS; Topol EJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1137-42. PubMed ID: 7897127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
    Cowley MJ; Vandermael M; Topol EJ; Whitlow PL; Dean LS; Bulle TM; Ellis SG
    J Am Coll Cardiol; 1993 Nov; 22(5):1289-97. PubMed ID: 8227782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients.
    Ruygrok PN; de Jaegere PT; van Domburg RT; van den Brand MJ; Serruys PW; de Feyter PJ
    J Am Coll Cardiol; 1996 Jun; 27(7):1669-77. PubMed ID: 8636552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-treated diabetes mellitus and predictors of mid-term clinical outcome after percutaneous coronary interventions with stent implantation.
    Tarantini G; Briguori C; Stankovic G; Takagi T; Corvaja N; Di Mario C; Colombo A
    Ital Heart J; 2003 Dec; 4(12):843-9. PubMed ID: 14976848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival?
    Bell MR; Bailey KR; Reeder GS; Lapeyre AC; Holmes DR
    J Am Coll Cardiol; 1990 Sep; 16(3):553-62. PubMed ID: 2387928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.
    Stein B; Weintraub WS; Gebhart SP; Cohen-Bernstein CL; Grosswald R; Liberman HA; Douglas JS; Morris DC; King SB
    Circulation; 1995 Feb; 91(4):979-89. PubMed ID: 7850985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.
    van den Brand MJ; Rensing BJ; Morel MA; Foley DP; de Valk V; Breeman A; Suryapranata H; Haalebos MM; Wijns W; Wellens F; Balcon R; Magee P; Ribeiro E; Buffolo E; Unger F; Serruys PW
    J Am Coll Cardiol; 2002 Feb; 39(4):559-64. PubMed ID: 11849851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
    Bypass Angioplasty Revascularization Investigation (BARI) Investigators
    N Engl J Med; 1996 Jul; 335(4):217-25. PubMed ID: 8657237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of long-term cardiac survival in patients with multivessel coronary artery disease undergoing percutaneous transluminal coronary angioplasty.
    Vandormael M; Deligonul U; Taussig S; Kern MJ
    Am J Cardiol; 1991 Jan; 67(1):1-6. PubMed ID: 1986494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA Registry.
    Bourassa MG; Yeh W; Holubkov R; Sopko G; Detre KM
    Eur Heart J; 1998 Jan; 19(1):103-11. PubMed ID: 9503182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.
    Robertson T; Kennard ED; Mehta S; Popma JJ; Carrozza JP; King SB; Holmes DR; Cowley MJ; Hornung CA; Kent KM; Roubin GS; Litvack F; Moses JW; Safian R; Desvigne-Nickens P; Detre KM
    Am J Cardiol; 1997 Nov; 80(10A):26K-39K. PubMed ID: 9409690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term analysis of conventional coronary balloon angioplasty and an initial "stent-like" result. The NHLBI PTCA Registry.
    Holmes DR; Kip KE; Yeh W; Kelsey SF; Detre KM; Williams DO
    J Am Coll Cardiol; 1998 Sep; 32(3):590-5. PubMed ID: 9741498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous transluminal coronary angioplasty as a first revascularization procedure in single-, double- and triple-vessel coronary artery disease.
    Weintraub WS; King SB; Douglas JS; Kosinski AS
    J Am Coll Cardiol; 1995 Jul; 26(1):142-51. PubMed ID: 7797743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization.
    Kloeter UC; Jander NG; Buser PT; Osswald S; Mueller-Brand J; Pfisterer ME
    Int J Cardiol; 2001 Jul; 79(2-3):197-205. PubMed ID: 11461742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.